In8bio
Price & Volume
Stats
See more52W Range | $0.21-$1.74 |
Market Cap | $25M |
Shares Short | 963,769 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.74 |
News
See moreYahoo Finance • last year
IN8bio’s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma
Yahoo Finance • last year
IN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual Meeting
Yahoo Finance • last year
IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
About
CEO | Mr. Tai-Wei Ho |
CFO | Mr. Patrick McCall CPA |
Address | 350 5th Avenue, New York, NY, United States, 10118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 39 |
